Kura Oncology, Inc. (KURA)

Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian's Launch and KO-7246 Preclinical Data in Diabetes

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Caspian Therapeutics Unveils KO-7246 at EASD as a Potential Best-In-Class Menin Inhibitor for Diabetes

Squarepoint Ops LLC Sells 78,432 Shares of Kura Oncology, Inc. $KURA

Kura Oncology, Inc. (KURA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes

Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KURA Stock Gains 37.6% in a Month: Here's What You Need to Know

Kura Oncology to Participate in Three Investor Conferences in September

Kura Oncology (KURA) Upgraded to Buy: What Does It Mean for the Stock?

Oncology Stocks to Add to Your Portfolio as Cancer Care Evolves

Kura Oncology: 'Strong Buy': Ziftomenib AML Expansions With Different Regimens Could Boost KOMZIFTI's Prospects

Kura Oncology CEO Buys 100,000 Shares for $1.2 Million. Does This Large Buy Bode Well for Shares in 2026?

Kura Oncology (KURA) CEO Purchases Shares Amid Positive KOMZIFTI Launch Metrics

Kura Oncology (KURA) is a Great Momentum Stock: Should You Buy?

Does Kura Oncology (KURA) Have the Potential to Rally 178.55% as Wall Street Analysts Expect?

Assenagon Asset Management S.A. Trims Holdings in Kura Oncology, Inc. $KURA

Kura Oncology, Inc. (KURA) Q2 2026 Earnings Call Transcript

Kura Oncology Q2 Earnings Call Highlights